scholarly journals Disease‐associated missense variants in ZBTB18 disrupt DNA binding and impair the development of neurons within the embryonic cerebral cortex

2019 ◽  
Vol 40 (10) ◽  
pp. 1841-1855 ◽  
Author(s):  
Isabel A. Hemming ◽  
Olivier Clément ◽  
Ivan E. Gladwyn‐Ng ◽  
Hayley D. Cullen ◽  
Han Leng Ng ◽  
...  
2012 ◽  
Author(s):  
Lucia Guidugli ◽  
Vernon Shane Pankratz ◽  
Catherine A. Erding ◽  
David E. Goldgar ◽  
Fergus J. Couch

PLoS ONE ◽  
2011 ◽  
Vol 6 (10) ◽  
pp. e26622 ◽  
Author(s):  
Valérie Mongrain ◽  
Francesco La Spada ◽  
Thomas Curie ◽  
Paul Franken

Author(s):  
Dulce Lima Cunha ◽  
Nicholas Owen ◽  
Vijay Tailor ◽  
Marta Corton ◽  
Maria Theodorou ◽  
...  

Abstract PAX6 is considered the master regulator of eye development, the majority of variants affecting this gene cause the pan-ocular developmental eye disorder aniridia. Although no genotype-phenotype correlations are clearly established, missense variants affecting the DNA-binding paired domain of PAX6 are usually associated with non-aniridia phenotypes like microphthalmia, coloboma or isolated foveal hypoplasia. In this study, we report two missense heterozygous variants in the paired domain of PAX6 resulting in isolated foveal hypoplasia with nystagmus in two independent families: c.112 C > G; p.(Arg38Gly) and c.214 G > C; p.(Gly72Arg) in exons 5 and 6, respectively. Furthermore, we provide evidence that paternal postzygotic mosaicism is the cause of inheritance, with clinically unaffected fathers and reduced affected allele fraction. This work contributes to increase the phenotypic spectrum caused by PAX6 variants, and to our knowledge, is the first report to describe the presence of postzygotic parental mosaicism causing isolated foveal hypoplasia with nystagmus. These results support the growing evidence that suggest an overestimation of sporadic cases with PAX6 variants, which has strong implications for both genetic counselling and family planning.


Science ◽  
2019 ◽  
Vol 365 (6453) ◽  
pp. 599-604 ◽  
Author(s):  
Steffen Boettcher ◽  
Peter G. Miller ◽  
Rohan Sharma ◽  
Marie McConkey ◽  
Matthew Leventhal ◽  
...  

TP53, which encodes the tumor suppressor p53, is the most frequently mutated gene in human cancer. The selective pressures shaping its mutational spectrum, dominated by missense mutations, are enigmatic, and neomorphic gain-of-function (GOF) activities have been implicated. We used CRISPR-Cas9 to generate isogenic human leukemia cell lines of the most common TP53 missense mutations. Functional, DNA-binding, and transcriptional analyses revealed loss of function but no GOF effects. Comprehensive mutational scanning of p53 single–amino acid variants demonstrated that missense variants in the DNA-binding domain exert a dominant-negative effect (DNE). In mice, the DNE of p53 missense variants confers a selective advantage to hematopoietic cells on DNA damage. Analysis of clinical outcomes in patients with acute myeloid leukemia showed no evidence of GOF for TP53 missense mutations. Thus, a DNE is the primary unit of selection for TP53 missense mutations in myeloid malignancies.


2012 ◽  
Vol 73 (1) ◽  
pp. 265-275 ◽  
Author(s):  
Lucia Guidugli ◽  
Vernon S. Pankratz ◽  
Namit Singh ◽  
James Thompson ◽  
Catherine A. Erding ◽  
...  

2020 ◽  
Author(s):  
Isabel A. Hemming ◽  
Steven Blake ◽  
Mark Agostino ◽  
Julian I‐T. Heng

2020 ◽  
Author(s):  
Suzana Herculano‐Houzel ◽  
Felipe Barros Cunha ◽  
Jamie L. Reed ◽  
Consolate Kaswera‐Kyamakya ◽  
Emmanuel Gillissen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document